|Bid||83.80 x 1400|
|Ask||84.62 x 1100|
|Day's range||82.02 - 84.65|
|52-week range||81.87 - 131.73|
|Beta (5Y monthly)||1.14|
|PE ratio (TTM)||62.45|
|Earnings date||25 Oct 2022 - 31 Oct 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||119.65|
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
To get a sense of who is truly in control of Edwards Lifesciences Corporation ( NYSE:EW ), it is important to...
Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.